Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients

This publication has 25 references indexed in Scilit:

• Intravenous immunoglobulin therapy in rheumatic diseases
  Nature Reviews Rheumatology, 2011
• Myopathies related to systemic sclerosis: a case–control study of associated clinical and immunological features
  Scandinavian Journal of Rheumatology, 2010
• A descriptive and prognostic study of systemic sclerosis-associated myopathies
  Annals of the Rheumatic Diseases, 2009
• Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects
  Clinical Rheumatology, 2008
• The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases
  Expert Review of Clinical Immunology, 2007
• Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study
  Annals of the Rheumatic Diseases, 2007
• Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
  Annals of the Rheumatic Diseases, 2007
• A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusion
  Rheumatology, 2005
• Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: An open‐label study
  Arthritis & Rheumatism, 2004
• A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
  New England Journal of Medicine, 1993